Wen-Wu Li1, Karen-Amanda Irvine, Peyman Sahbaie, Tian-Zhi Guo, Xiao-You Shi, Vivianne L Tawfik, Wade S Kingery, J David Clark. 1. From the Anesthesiology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, and Department of Anesthesiology, Stanford University School of Medicine, Stanford, California (W.-W.L., K.-A.I., P.S., X.-y.S., J.D.C.) Physical Medicine and Rehabilitation Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California (T.-Z.G., W.S.K.) Department of Anesthesiology, Perioperative & Pain Medicine, Stanford University School of Medicine, Stanford, California (V.L.T.).
Abstract
BACKGROUND: Emerging evidence suggests that opioid use immediately after surgery and trauma may worsen outcomes. In these studies, the authors aimed to determine whether morphine administered for a clinically relevant time period (7 days) in a tibia fracture orthopedic surgery model had adverse effects on postoperative recovery. METHODS: Mice were given morphine twice daily for 7 days after unilateral tibial fracture and intramedullary pin fixation to model orthopedic surgery and limb trauma. Mechanical allodynia, limb-specific weight bearing, gait changes, memory, and anxiety were measured after injury. In addition, spinal cord gene expression changes as well as glial activation were measured. Finally, the authors assessed the effects of a selective Toll-like receptor 4 antagonist, TAK-242, on nociceptive and functional changes after injury. RESULTS: Tibial fracture caused several weeks of mechanical nociceptive sensitization (F(1, 216) = 573.38, P < 0.001, fracture + vehicle vs. sham + vehicle, n = 10 per group), and this change was exacerbated by the perioperative administration of morphine (F(1, 216) = 71.61, P < 0.001, fracture + morphine vs. fracture + vehicle, n = 10 per group). In additional testing, injured limb weight bearing, gait, and object location memory were worse in morphine-treated fracture mice than in untreated fracture mice. Postfracture expression levels of several genes previously associated with opioid-induced hyperalgesia, including brain-derived neurotrophic factor and prodynorphin, were unchanged, but neuroinflammation involving Toll-like receptor 4 receptor-expressing microglia was observed (6.8 ± 1.5 [mean ± SD] cells per high-power field for fracture + vehicle vs. 12 ± 2.8 fracture + morphine, P < 0.001, n = 8 per /group). Treatment with a Toll-like receptor 4 antagonist TAK242 improved nociceptive sensitization for about 2 weeks in morphine-treated fracture mice (F(1, 198) = 73.36, P < 0.001, fracture + morphine + TAK242 vs. fracture + morphine, n = 10 per group). CONCLUSIONS: Morphine treatment beginning at the time of injury impairs nociceptive recovery and other outcomes. Measures preventing glial activation through Toll-like receptor 4 signaling may reduce the adverse consequences of postoperative opioid administration.
BACKGROUND: Emerging evidence suggests that opioid use immediately after surgery and trauma may worsen outcomes. In these studies, the authors aimed to determine whether morphine administered for a clinically relevant time period (7 days) in a tibia fracture orthopedic surgery model had adverse effects on postoperative recovery. METHODS:Mice were given morphine twice daily for 7 days after unilateral tibial fracture and intramedullary pin fixation to model orthopedic surgery and limb trauma. Mechanical allodynia, limb-specific weight bearing, gait changes, memory, and anxiety were measured after injury. In addition, spinal cord gene expression changes as well as glial activation were measured. Finally, the authors assessed the effects of a selective Toll-like receptor 4 antagonist, TAK-242, on nociceptive and functional changes after injury. RESULTS:Tibial fracture caused several weeks of mechanical nociceptive sensitization (F(1, 216) = 573.38, P < 0.001, fracture + vehicle vs. sham + vehicle, n = 10 per group), and this change was exacerbated by the perioperative administration of morphine (F(1, 216) = 71.61, P < 0.001, fracture + morphine vs. fracture + vehicle, n = 10 per group). In additional testing, injured limb weight bearing, gait, and object location memory were worse in morphine-treated fracturemice than in untreated fracturemice. Postfracture expression levels of several genes previously associated with opioid-induced hyperalgesia, including brain-derived neurotrophic factor and prodynorphin, were unchanged, but neuroinflammation involving Toll-like receptor 4 receptor-expressing microglia was observed (6.8 ± 1.5 [mean ± SD] cells per high-power field for fracture + vehicle vs. 12 ± 2.8 fracture + morphine, P < 0.001, n = 8 per /group). Treatment with a Toll-like receptor 4 antagonist TAK242 improved nociceptive sensitization for about 2 weeks in morphine-treated fracturemice (F(1, 198) = 73.36, P < 0.001, fracture + morphine + TAK242 vs. fracture + morphine, n = 10 per group). CONCLUSIONS:Morphine treatment beginning at the time of injury impairs nociceptive recovery and other outcomes. Measures preventing glial activation through Toll-like receptor 4 signaling may reduce the adverse consequences of postoperative opioid administration.
Authors: Seshadri C Mudumbai; Elizabeth M Oliva; Eleanor T Lewis; Jodie Trafton; Daniel Posner; Edward R Mariano; Randall S Stafford; Todd Wagner; J David Clark Journal: Pain Med Date: 2016-04-15 Impact factor: 3.750
Authors: Robert E Sorge; Josiane C S Mapplebeck; Sarah Rosen; Simon Beggs; Sarah Taves; Jessica K Alexander; Loren J Martin; Jean-Sebastien Austin; Susana G Sotocinal; Di Chen; Mu Yang; Xiang Qun Shi; Hao Huang; Nicolas J Pillon; Philip J Bilan; YuShan Tu; Amira Klip; Ru-Rong Ji; Ji Zhang; Michael W Salter; Jeffrey S Mogil Journal: Nat Neurosci Date: 2015-06-29 Impact factor: 24.884
Authors: Theresa Alexandra Mattioli; Heather Leduc-Pessah; Graham Skelhorne-Gross; Chris J B Nicol; Brian Milne; Tuan Trang; Catherine M Cahill Journal: PLoS One Date: 2014-05-13 Impact factor: 3.240
Authors: Mark R Hutchinson; Sondra T Bland; Kirk W Johnson; Kenner C Rice; Steven F Maier; Linda R Watkins Journal: ScientificWorldJournal Date: 2007-11-02
Authors: Luke G McVeigh; Anthony J Perugini; Jill C Fehrenbacher; Fletcher A White; Melissa A Kacena Journal: Curr Osteoporos Rep Date: 2020-10 Impact factor: 5.096
Authors: Suzanne M Green-Fulgham; Jayson B Ball; Andrew J Kwilasz; Timothy Fabisiak; Steven F Maier; Linda R Watkins; Peter M Grace Journal: Pain Date: 2019-11 Impact factor: 7.926
Authors: Gijsje J L J Snijders; Marjolein A M Sneeboer; Alba Fernández-Andreu; Evan Udine; Marco P Boks; Paul R Ormel; Amber Berdenis van Berlekom; Hans C van Mierlo; Chotima Bӧttcher; Josef Priller; Towfique Raj; Elly M Hol; René S Kahn; Lot D de Witte Journal: Mol Psychiatry Date: 2020-10-07 Impact factor: 13.437
Authors: R Magnusdottir; S Gohin; F Ter Heegde; M Hopkinson; I F McNally; A Fisher; N Upton; A Billinton; C Chenu Journal: Osteoporos Int Date: 2021-06-02 Impact factor: 4.507